Candriam S.C.A. Intra Cellular Therapies, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 164,132 shares of ITCI stock, worth $14.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

164,132

Holding current value

$14.4 Million

% of portfolio

0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$67.99 - $80.84 $11.2 Million - $13.3 Million	164,132 New	164,132 $12 Million
Q1 2022 May 13, 2022	SELL	$38.74 - $62.09 $3.17 Million - $5.07 Million	-81,710 Reduced 69.47%	35,907 $2.2 Million
Q4 2021 Feb 10, 2022	SELL	$35.2 - $53.42 $12.9 Million - $19.7 Million	-367,849 Reduced 75.77%	117,617 $6.16 Million
Q3 2021 Nov 09, 2021	BUY	$28.72 - $42.49 $4.77 Million - $7.05 Million	165,979 Added 51.95%	485,466 $18.1 Million
Q2 2021 Jul 20, 2021	SELL	$29.3 - $44.5 $4 Million - $6.08 Million	-136,535 Reduced 29.94%	319,487 $13 Million
Q4 2020 Jan 22, 2021	BUY	$23.34 - $32.22 $607,353 - $838,428	26,022 Added 6.05%	456,022 $14.5 Million
Q3 2020 Oct 19, 2020	SELL	$17.61 - $31.86 $2.47 Million - $4.46 Million	-140,000 Reduced 24.56%	430,000 $11 Million
Q2 2020 Jul 23, 2020	SELL	$14.35 - $26.64 $4.64 Million - $8.6 Million	-323,000 Reduced 36.17%	570,000 $14.6 Million
Q4 2019 Jan 21, 2020	SELL	$7.26 - $38.49 $181,500 - $962,250	-25,000 Reduced 2.72%	893,000 $31,000
Q3 2019 Oct 21, 2019	BUY	$7.47 - $14.03 $2.99 Million - $5.61 Million	400,000 Added 77.22%	918,000 $7,000
Q2 2019 Aug 01, 2019	SELL	$10.65 - $14.29 $1.49 Million - $2 Million	-140,000 Reduced 21.28%	518,000 $6.69 Million
Q1 2019 May 02, 2019	BUY	$10.9 - $14.09 $218,000 - $281,800	20,000 Added 3.13%	658,000 $8.02 Million
Q4 2018 Feb 14, 2019	BUY	$10.36 - $20.96 $932,400 - $1.89 Million	90,000 Added 16.42%	638,000 $7.27 Million
Q3 2018 Nov 07, 2018	BUY	$17.77 - $22.9 $5.53 Million - $7.12 Million	311,000 Added 131.22%	548,000 $11.9 Million
Q2 2018 Aug 14, 2018	BUY	$17.33 - $23.4 $329,269 - $444,600	19,000 Added 8.72%	237,000 $4.19 Million
Q1 2018 May 09, 2018	SELL	$15.16 - $25.49 $939,920 - $1.58 Million	-62,000 Reduced 22.14%	218,000 $4.59 Million
Q4 2017 Feb 07, 2018	BUY	$14.27 - $16.79 $1.47 Million - $1.73 Million	103,000 Added 58.19%	280,000 $4.05 Million
Q3 2017 Nov 03, 2017	BUY	$10.77 - $22.1 $1.91 Million - $3.91 Million	177,000	177,000 $2.79 Million

Others Institutions Holding ITCI

# of Institutions

377

Shares Held

85M

Call Options Held

299K

Put Options Held

130K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.27B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account